Oncology & Cancer

Promising new research on aggressive breast cancer

Better treatments of HER2-positive breast cancer are closer at hand, thanks to new research by a team led by Université de Montréal professor Jean-François Côté at the cytoskeleton organization and cell-migration research ...

Oncology & Cancer

New insights into how the drug pomalidomide fights cancer

Multiple myeloma is a cancer of the white blood cells, and patients diagnosed with this disease commonly die within five years. Clinicians often treat multiple myeloma with the drug thalidomide and structurally similar drugs ...

Oncology & Cancer

Novel therapeutic approaches for aggressive bone cancer

Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic ...

Oncology & Cancer

Extra chromosomes in cancers can be good or bad

Cancer cells are notorious for their genetic disarray. A tumor cell can contain an abundance of DNA mutations and most have the wrong number of chromosomes. A missing or extra copy of a single chromosome creates an imbalance ...

page 3 from 28